Cytotoxic Lesions of the Corpus Callosum Caused by Thermogenic Dietary Supplements

REFERENCES

1. 1.↵
   2. Blanck HM,
   3. Serdula MK,
   4. Gillespie C, et al

   . Use of nonprescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc 2007;107:441–47 doi:10.1016/j.jada.2006.12.009 pmid:17324663

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Hoffman JR,
   3. Kang J,
   4. Ratamess NA, et al

   . Thermogenic effect of an acute ingestion of a weight loss supplement. J Int Soc Sports Nutr 2009;6:1 doi:10.1186/1550-2783-6-1 pmid:19126212

   CrossRefPubMed
3. 3.↵
   2. Olivas-Chacon C,
   3. Treviño-García M,
   4. Chua-Tuan J, et al

   . Leukoencephalopathic changes on magnetic resonance imaging associated with a thermogenic dietary supplement (Thermatrim). Proc (Bayl Univ Med Cent) 2015;28:389–91 doi:10.1080/08998280.2015.11929288 pmid:26130900

   CrossRefPubMed
4. 4.↵
   2. Starkey J,
   3. Kobayashi N,
   4. Numaguchi Y, et al

   . Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics 2017;37:562–76 doi:10.1148/rg.2017160085 pmid:28165876

   CrossRefPubMed
5. 5.↵
   2. Rimkus CM,
   3. Andrade CS,
   4. Leite C, et al

   . Toxic leukoencephalopathies, including drug, medication, environmental, and radiation-induced encephalopathic syndromes. Semin Ultrasound CT MR 2014;35:97–117 doi:10.1053/j.sult.2013.09.005 pmid:24745887

   CrossRefPubMed
6. 6.↵
   2. Diepvens K,
   3. Westerterp KR,
   4. Westerterp-Plantenga MS

   . Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am J Physiol Regul Integr Comp Physiol 2007;292:R77–85 doi:10.1152/ajpregu.00832.2005 pmid:16840650

   CrossRefPubMed
7. 7.↵
   2. Liu AG,
   3. Smith SR,
   4. Fujioka K, et al

   . The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss. Obesity (Silver Spring) 2013;21:1991–96 doi:10.1002/oby.20416 pmid:23686786

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Evans JL

   . Diet, botanical and nutritional treatments for type 2 diabetes. 2003. https://www.endotext.org/. Accessed June 13, 2019.
9. 9.↵
   2. da Silva WV,
   3. de Andrade Gomes Silva MI,
   4. Tavares Toscano L, et al

   . Supplementation prevalence and adverse effects in physical exercise practitioners. Nutr Hosp 2014;29:158–65 doi:10.3305/nh.2014.29.1.6853 pmid:24483975

   CrossRefPubMed
10. 10.↵
    2. Sathananthasarma P,
    3. Weeratunga PN,
    4. Chang T

    . Reversible splenial lesion syndrome associated with dengue fever: a case report. BMC Res Notes 2018;11:9–12 doi:10.1186/s13104-018-3491-6 pmid:29945676

    CrossRefPubMed
11. 11.↵
    2. Singh P,
    3. Gogoi D,
    4. Vyas S, et al

    . Transient splenial lesion: further experience with two cases. Indian J Radiol Imaging 2010;20:254–57 doi:10.4103/0971-3026.73531 pmid:21423898

    CrossRefPubMed
12. 12.↵
    2. Cho JS,
    3. Ha SW,
    4. Han YS, et al

    . Mild encephalopathy with reversible lesion in the splenium of the corpus callosum and bilateral frontal white matter. J Clin Neurol 2007;3:53–56 doi:10.3988/jcn.2007.3.1.53 pmid:19513344

    CrossRefPubMed
13. 13.↵
    2. Zheng W

    . Neurotoxicology of the brain barrier system: new implications. J Toxicol Clin Toxicol 2001;39:711–19 doi:10.1081/CLT-100108512 pmid:11778669

    CrossRefPubMedWeb of Science
14. 14.↵
    2. McKinney AM,
    3. Kieffer SA,
    4. Paylor RT, et al

    . Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion weighted and FLAIR imaging. AJR Am J Roentgenol 2009;193:192–206 doi:10.2214/AJR.08.1176 pmid:19542414

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Hagan IG,
    3. Burney K

    . Radiology of recreational drug abuse. Radiographics 2007;27:919–40 doi:10.1148/rg.274065103 pmid:17620459

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Hassel B,
    3. Boldingh KA,
    4. Narvesen C, et al

    . Glutamate transport, glutamine synthetase and phosphate-activated glutaminase in rat CNS white matter: a quantitative study. J Neurochem 2003;87:230–37 doi:10.1046/j.1471-4159.2003.01984.x pmid:12969269

    CrossRefPubMed
17. 17.↵
    2. Domercq M,
    3. Matute C

    . Expression of glutamate transporters in the adult bovine corpus callosum. Brain Res Mol Brain Res 1999;67:296–302 doi:10.1016/S0169-328X(99)00072-8 pmid:10216228

    CrossRefPubMed
18. 18.↵
    Cofepris. LA COFEPRIS ALERTA SOBRE EL PRODUCTO THERMATRIM. Secretaría de Salud: Comunicado de prensa 2014. https://www.gob.mx/salud/prensa/la-cofepris-alerta-sobre-el-producto-thermatrim. Accessed June 13, 2019.
19. 19.↵
    Food Alert Network. Efectos adversos relacionados con el consumo del complemento alimenticio (Pura Alegría) procedente de México 2015. http://www.aecosan.msssi.gob.es/AECOSAN/web/seguridad_alimentaria/ampliacion/complemento_alimenticio_PURA_ALEGRIA.htm. Accessed June 13, 2019.
20. 20.↵
    2. Kakkar C,
    3. Prakashini K,
    4. Polnaya A

    . Acute Marchiafava Bignami disease: clinical and serial MRI correlation. BMJ Case Rep 2014;2014 doi:10.1136/bcr-2013-203442 pmid:24850553

    Abstract/FREE Full Text